Ignite Creation Date:
2025-12-26 @ 1:18 PM
Ignite Modification Date:
2026-04-15 @ 8:55 AM
Study NCT ID:
NCT05559606
Status:
COMPLETED
Last Update Posted:
2025-09-12
First Post:
2022-09-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An OS to Evaluate the Safety & Efficacy of Fixed Dose Combination Therapy With Atorvastatin and Ezetimibe
Sponsor:
Boryung Pharmaceutical Co., Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BR-EAC-OS-401
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None